Indias weight-loss market is the Wild West right now: self-medicating, grey imports, Instagram sellers, no diagnostics, no supervision - not to mention a wide array of GLP1 probiotics/supplements that don't work
Regulatory Landscape Regulation for GLP-1 agonists is tightening around product quality, lawful supply, and label governance as demand expands across diabetes and obesity
For women in their 40s and 50s, the timing can overlap
Test 2: Ultimate C Rating Test In the ultimate C rating test, the results did not improvein fact, the Zeee batteries once again showed significant underperformance
Industry Developments: As of May 2024, around 38 million Americans live with diabetes, with 90-95% having type 2 diabetes-a condition increasingly affecting younger populations